Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 1;38(3):236-242.
doi: 10.1097/WCO.0000000000001359. Epub 2025 Mar 19.

Multiple sclerosis in China: the current state of diagnosis and management

Dongmei Jia  1 , Fu-Dong Shi  1   2 , Wei Jiang  1
Affiliations
Review

Multiple sclerosis in China: the current state of diagnosis and management

Dongmei Jia et al. Curr Opin Neurol. .

Abstract

Purpose of review: This comprehensive overview summarized the latest advances of multiple sclerosis (MS) in China, including the diagnostic and treatment challenges, research and future directions under health policy recommendations.

Recent findings: Given the rising prevalence of MS in China during the past decades, it has emerged as a significant public health concern due to the extensive population and pronounced disparities between urban and rural areas. The clinical manifestations of MS patients in China can be various due to the nation's diversity and evolving environmental factors. Advances in diagnostic practices, including the advances under 7T MRI radiological assessments, have enhanced the precision of MS diagnosis. Despite the introduction of disease-modifying therapeutic agents and the support of healthcare policies offering patients a wider range of treatment options, multiple ongoing research efforts and clinical trials will provide additional evidence. The ongoing China National Registry of Neuro-Inflammatory Diseases study (NCT05154370) holds promise for further enhancing the management of MS patients in China.

Summary: Improved recognition and management of MS in China have been facilitated, encompassing both prompt diagnosis and diverse treatment options. Simultaneously, research efforts and large-scale cohort studies have significantly advanced the overall status in this field.

Keywords: diagnosis; disease-modifying therapies; multiple sclerosis.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Thompson AJ, Baranzini SE, Geurts J, et al. Multiple sclerosis. Lancet 2018; 391:1622–1636.
    1. Reich DS, Lucchinetti CF, Calabresi PA. Multiple sclerosis. N Engl J Med 2018; 378:169–180.
    1. Zhang GX, Carrillo-Vico A, Zhang WT, et al. Incidence and prevalence of multiple sclerosis in China and other Asian countries. Neurologia (Engl Ed) 2023; 38:159–172.
    1. Jia D, Zhang Y, Yang C. The incidence and prevalence, diagnosis, and treatment of multiple sclerosis in China: a narrative review. Neurol Sci 2022; 43:4695–4700.
    1. Zhang C, Liu W, Wang L, et al. Prevalence and burden of multiple sclerosis in China, 1990–2019: findings from the Global Burden of Disease Study 2019. Neurology 2024; 102:e209351.

MeSH terms